NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
May 03 2024 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three months ended
March 31, 2024 after market close on Thursday, May 9, 2024 and will
hold an investment community conference call that day beginning at
4:30 p.m. Eastern time.
Date/Time:
Thursday, May 9, 4:30 p.m. ET / 1:30
p.m. PT
Pre-Registration:
Participants can pre-register for the
conference call here:
Callers who pre-register will be emailed
conference details and unique Registration ID to gain immediate
access to the call and bypass the live operator. Participants may
pre-register at any time, including up to and after the call start
time.
Dial In:
Those who choose not to pre-register can
access the live conference call by dialing the following and
requesting conference call ID# 85516:
888-500-3691 from within the U.S.
646-307-1951 from outside the
U.S.
The live webcast of the conference call also will be available
on the Events section of the Company website. A replay of the call
will be available beginning three hours after its completion
through June 9, 2024 by dialing 877-660-6853 from within the U.S.
or 201-612-7415 from outside the U.S., and entering conference ID
13746453. The webcast will also be archived here.
About NovaBay Pharmaceuticals, Inc: NovaBay
Pharmaceuticals, Inc. develops and sells scientifically created and
clinically proven eyecare, skincare and wound care products.
NovaBay’s leading product Avenova® Antimicrobial Lid & Lash
Solution is often prescribed by eyecare professionals for
blepharitis and dry-eye disease and is also available directly to
consumers through online distribution channels such as Amazon.com.
NovaBay also manufactures and sells effective, yet gentle and
non-irritating wound care products. The PhaseOne® brand is
distributed through commercial partners in the U.S. for
professional use only, and the NeutroPhase® brand is distributed in
China by China Pioneer Pharma Holdings, Limited. More information
about NovaBay is available here.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on X
Connect with NovaBay on LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240503632804/en/
NovaBay Justin Hall Chief
Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor LHA Investor
Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2024 to Oct 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Oct 2023 to Oct 2024